SterRx, LLC 2023-07-26 Health serious FDA
Health · FDA · Recall #FDA-D-0931-2023
Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single… Recall
Issued July 26, 2023 · SterRx, LLC
In July 2023, SterRx, LLC recalled the Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of Assurance of Sterility
What you should do
- 1 Stop using Norepinephrine 4 mg per 250 mL (16 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact SterRx, LLC to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- SterRx, LLC
- Category
- Health
- Recall date
- July 26, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0931-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- SterRx, LLC has 14 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.